GlassScriptPhysician profile
Judy W Tom
NPI 1437140589
$420.64
in general payments reported to CMS, 2019-2025
16 companies · $5.38 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $59.68 · 2021: $57.54 · 2022: $14.28 · 2023: $28.15 · 2024: $31.86 · 2025: $5.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $65.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $65.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $66.93 | 2019-2021 | |
| Daiichi Sankyo INC. | $48.33 | 2019-2020 | |
| Avion Pharmaceuticals | $43.14 | 2020-2021 | |
| Amag Pharmaceuticals, INC. | $42.41 | 2019 | |
| Hologic Sales and Service, LLC | $41.85 | 2019-2024 | Myosure Tissue Removal Device, Novasure |
| Bayer Healthcare Pharmaceuticals INC. | $29.33 | 2019 | |
| Merck Sharp & Dohme LLC | $27.94 | 2019 | |
| Lupin INC. | $23.13 | 2019 | |
| Gynesonics, INC. | $20.89 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Optumhealth Care Solutions, LLC | $16.98 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Boston Scientific Corporation | $14.28 | 2022 | |
| Mayne Pharma Commercial LLC | $12.64 | 2023-2025 | |
| Duchesnay USA Incorporated | $11.44 | 2019 | |
| Pfizer INC. | $10.82 | 2019 | |
| Aspira Women'S Health INC | $10.53 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judy Tom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.